Genmab — September 2018
-
Helge..De skyder pænt galt på Genmab i den undersøgelse.
-
-
Er der nogen der har forstået hvordan den store forskel på kurstarget mellem alle analytikerne opstår, når de fleste er enige om topsalgs estimaterne? Pga deres forskellige opfattelse af et rimeligt langsigtet PE.. eller hvad. Ingen synes jo at tage megen højde for pipeline, som jeg forstår det.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind